ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
Ab Science

Ab Science (AB)

1.75
-0.032
(-1.80%)
마감 18 1월 1:30AM

개인 투자자를 위한 전문가급 도구.

주요 통계 및 세부정보

가격
1.75
매수가
1.71
매도가
1.80
거래량
166,947
1.66 일간 변동폭 1.822
0.77 52주 범위 4.465
market_cap
전일 종가
1.782
개장가
1.82
최근 거래 시간
1
@
1.75
마지막 거래 시간
재정 규모
-
VWAP
-
평균 볼륨(3m)
158,564
발행 주식
52,071,069
배당수익률
-
주가수익률
-7.60
주당순이익(EPS)
-0.23
매출
970k
순이익
-11.99M

Ab Science 정보

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
본부
Paris, Paris, Fra
설립됨
-
Ab Science is listed in the Pharmaceutical Preparations sector of the 유로넥스트 (Euronext) with ticker AB. The last closing price for Ab Science was 1.78 €. Over the last year, Ab Science shares have traded in a share price range of 0.77 € to 4.465 €.

Ab Science currently has 52,071,069 shares in issue. The market capitalisation of Ab Science is 92.79 € million. Ab Science has a price to earnings ratio (PE ratio) of -7.60.

AB 최신 뉴스

AB Science fournit un résumé de la conférence virtuelle qui s’est tenue le 16 décembre 2024

AB Science fournit un résumé de la conférence virtuelle qui s’est tenue le 16 décembre 2024 COMMUNIQUÉ DE PRESSE AB SCIENCE FAIT LE POINT SUR LA MOLECULE AB8939, UN NOUVEAU DÉSTABILISATEUR DE...

AB Science provides a summary of the webcast held on December 16, 2024

AB Science provides a summary of the webcast held on December 16, 2024 PRESS RELEASE AB SCIENCE PROVIDES AN UPDATE ON AB8939, A NOVEL MICROTUBULE DESTABILIZER ESCAPING MULTIDRUG RESISTANCE AND...

AB Science provides a summary of the webcast held on December 16, 2024

PRESS RELEASE AB SCIENCE PROVIDES AN UPDATE ON AB8939, A NOVEL MICROTUBULE DESTABILIZER ESCAPING MULTIDRUG RESISTANCE AND STEM CELL TARGETED ALDH INHIBITOR, CURRENTLY IN PHASE 1 Paris, 17 December...

AB Science tiendra une conférence virtuelle le lundi 16 décembre 2024, de 17h30 à 18h30

AB Science tiendra une conférence virtuelle le lundi 16 décembre 2024, de 17h30 à 18h30 COMMUNIQUE DE PRESSE AB SCIENCE TIENDRA UNE CONFERENCE VIRTUELLE LE LUNDI 16 DECEMBRE 2024, DE 17H30 A 18H30...

AB Science will host a live webcast on Monday December 16, 2024, from 5.30pm to 6.30pm CET

PRESS RELEASE AB SCIENCE WILL HOST A LIVE WEBCAST ON MONDAY DECEMBER 16, 2024 FROM 5.30PM TO 6.30PM CET Paris, 11 December, 2024, 6pm CET AB Science SA (Euronext – FR0010557264 – AB) will host...

AB Science will host a live webcast on Monday December 16, 2024, from 5.30pm to 6.30pm CET

AB Science will host a live webcast on Monday December 16, 2024, from 5.30pm to 6.30pm CET PRESS RELEASE AB SCIENCE WILL HOST A LIVE WEBCAST ON MONDAY DECEMBER 16, 2024 FROM 5.30PM TO 6.30PM CET...

AB Science reçoit un avis d’acceptation pour le brevet européen couvrant jusqu’en 2040 le masitinib dans le traitement de la drépanocytose

AB Science reçoit un avis d’acceptation pour le brevet européen couvrant jusqu’en 2040 le masitinib dans le traitement de la drépanocytose COMMUNIQUE DE PRESSE AB SCIENCE REÇOIT UN AVIS...

AB Science receives notice of allowance for European patent covering masitinib until 2040 in the treatment of sickle cell disease

AB Science receives notice of allowance for European patent covering masitinib until 2040 in the treatment of sickle cell disease PRESS RELEASE AB SCIENCE RECEIVES NOTICE OF ALLOWANCE FOR EUROPEAN...

AB Science receives notice of allowance for European patent covering masitinib until 2040 in the treatment of sickle cell disease

PRESS RELEASE AB SCIENCE RECEIVES NOTICE OF ALLOWANCE FOR EUROPEAN PATENT COVERING MASITINIB UNTIL 2040 IN THE TREATMENT OF SICKLE CELL DISEASE THIS DECISION FURTHER STRENGTHENS MASITINIB’S...

AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALS

PRESS RELEASE AB SCIENCE PROVIDES AN UPDATE ON THE APPLICATION FOR CONDITIONAL MARKETING AUTHORISATION OF MASITINIB IN THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS Paris, 17 October, 2024...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-0.07-3.846153846151.821.9481.4622361871.70094023DE
40.8390.21739130430.922.340.8754229791.7590328DE
120.76477.48478701830.9862.340.771585641.58141137DE
260.73271.9056974461.0182.340.77878551.46768495DE
52-1.79-50.56497175143.544.4650.771155981.90806794DE
156-10.25-85.416666666712120.771036714.19147324DE
260-5.97-77.33160621767.7221.750.771479358.32992115DE

AB - Frequently Asked Questions (FAQ)

What is the current Ab Science share price?
The current share price of Ab Science is 1.75 €
How many Ab Science shares are in issue?
Ab Science has 52,071,069 shares in issue
What is the market cap of Ab Science?
The market capitalisation of Ab Science is EUR 92.79M
What is the 1 year trading range for Ab Science share price?
Ab Science has traded in the range of 0.77 € to 4.465 € during the past year
What is the PE ratio of Ab Science?
The price to earnings ratio of Ab Science is -7.6
What is the cash to sales ratio of Ab Science?
The cash to sales ratio of Ab Science is 94.09
What is the reporting currency for Ab Science?
Ab Science reports financial results in EUR
What is the latest annual turnover for Ab Science?
The latest annual turnover of Ab Science is EUR 970k
What is the latest annual profit for Ab Science?
The latest annual profit of Ab Science is EUR -11.99M
What is the registered address of Ab Science?
The registered address for Ab Science is 3 AVENUE GEORGE V, PARIS, PARIS, 75008
What is the Ab Science website address?
The website address for Ab Science is www.ab-science.com
Which industry sector does Ab Science operate in?
Ab Science operates in the PHARMACEUTICAL PREPARATIONS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
DRVDSDrone Volt
0.0039 €
(3,800.00%)
774.48k
GTRDSGroupe Tera DS
0.0585 €
(800.00%)
3.27k
ALCYBCybergun
0.0002 €
(100.00%)
3.98M
DMSBSDiagnostic Medical Systems
0.0075 €
(87.50%)
129.59k
NICBSNicox SA
0.0265 €
(50.57%)
979
MLSMLSmalto
0.014 €
(-33.33%)
1.62k
ALVERVergnet
0.0015 €
(-21.05%)
97.17M
MLIDSIds
0.364 €
(-19.11%)
1.12k
MCPGrupo Media Capital Sgps Sa
1.62 €
(-19.00%)
3
ALBOOBOOSTHEAT
0.063 €
(-15.78%)
70.91k
ATOAtos SE
0.002 €
(-4.76%)
2.53B
ALVERVergnet
0.0015 €
(-21.05%)
97.17M
BCPBanco Comercial Portugues SA
0.4988 €
(0.79%)
69.25M
EDPEDP SA
3.149 €
(1.22%)
13.56M
VIVVivendi SE
2.546 €
(-1.01%)
8.93M
Werbe Werbe 4 분 전
Everyone that posts here start with some extraordinary story of upbringing or some sort of passive social shout.  Anyone a high-school dropout or start from welfare?  
CrypticDomain141 CrypticDomain141 6 분 전
I’ve done my research and I’m long.

I don’t understand why everyone is so shocked that this is still volatile at this time. It doesn’t have any revenue yet, and it doesn’t have a big pharm partner….yet.

But from the clinical trials it seems they’ve got the goods. The C
AVXL
Drugdoctor Drugdoctor 9 분 전
Here is our CEO's stock chart pattern... Soon we will see $SRNW sporting the same pattern.

https://investorshub.advfn.com/uimage/uploads/2025/1/17/yrkgpGVSI_1-17.png
SRNW
AlwaysOptimistic AlwaysOptimistic 10 분 전
I also saw that. Of course Chambers would take that position. He has a lot of capital invested in AI and other tech with his venture funding group (JC2 Ventures) and a lot to lose if investors siphon money away from AI in to quantum. Just like NVDIA. This too shall pass IMO.
IONQ
SSKILLZ1 SSKILLZ1 10 분 전
Why Pete would play there now is beyond me. Maybe he has a love of public humiliation?

I have no clue why either. At this point. Which is why I would be shocked if he comes back at this point.

One thing for sure: any Mets solution at first base that includes regularly p
4u2nv2 4u2nv2 10 분 전
I have looked at a lot of charts on IFUS. 1M, 1Y, 5Y and I specifically focused on the volume and PPS movement. I did say recently that I am not trading this stock. I do not own any or plan on buying it. I am more focused on a private business model than trading OTC or any stocks. But the IFUS PPS h
IFUS
nowwhat2 nowwhat2 10 분 전
Charts are just totally freaking SCREAMING that it COULD be a "Sell The News" Event......and yet ?

It's like.....



https://investorshub.advfn.com/uimage/uploads/2025/1/17/zvqmlxrp_!_17_hyper_845pm_CALVIN_INAUG_PARADE_ATH.jpg



XRPUSD
littlejohn littlejohn 11 분 전
SMCI will be at 47 to 48 in a Pop

before we can read the 10K

filing header...

That is why you gotta be ready before

it is filed...

Around $48 is the recent trading high

that market makers marked that may
SMCI
Drugdoctor Drugdoctor 12 분 전
Remember, assets from other stock mergers will be added to $FORW's holding company. Right now, something is happening with American Blockchain ($GVSI), our CEO's other shell, and if it is the first to merger, some assets will be coming here. Can't wait for $FORW's chart to look like this.
FORW
MONTANAJOE MONTANAJOE 12 분 전
Just amuse each other with their nonsense!
NBRI
TucsonPhil TucsonPhil 12 분 전
Wow. According to OTC markets, the OS count is now 5,988,649,454. Last time I checked was last year, and I recall it was around 3.9B, when the AS was 5B, then they raised the AS to 10B and have been busy with quite a bit of dilution.
KGKG
MONTANAJOE MONTANAJOE 12 분 전
Like it better when they just talk to each other and leave everyone else alone!!
NBRI
againstallodds againstallodds 14 분 전
https://investorshub.advfn.com/uimage/uploads/2025/1/17/rarvyIMG_0265.jpeg

0.5 oz of rhodium per ton of ore can be considered a very high-grade deposit. Here's why:
* Rhodium is extremely rare: It's one of the rarest and most valuable precious metals.
* Typical grades
NBRI
EarningsCentral EarningsCentral 17 분 전
TLRY
Drugdoctor Drugdoctor 18 분 전
Who made 300% gains-with-George-Sharp's-$GVSI??>>

https://investorshub.advfn.com/uimage/uploads/2025/1/17/yrkgpGVSI_1-17.png
GVSI
axelvento axelvento 19 분 전
Moderna is preparing to advance mRNA-1018 into Phase 3. The Company looks forward to sharing the Phase 1/2 results at an upcoming scientific meeting.
MRNA
gitreal gitreal 19 분 전
Could it be Mt Vernon assays are flawed, and that the extraordibary Rhodiun assays are skewed ?

Skewed? No.
Made up? Yes.
NBRI
Drugdoctor Drugdoctor 20 분 전
Check the accumulation line on chart>>>

https://investorshub.advfn.com/uimage/uploads/2025/1/17/yrkgpGVSI_1-17.png
GVSI
sylvia07 sylvia07 20 분 전
Where are the BASHERS when good news is announced, always missing?
GRST
dinogreeves dinogreeves 20 분 전
Only time will tell which direction they take. In either case, let's get the FID first and hopefully merger not too long after. This is ripe for massive move, with the latest on the media and the Senators in the mix, now imagine that with the merger news and Motley Fool article a long while back w
TGLO
againstallodds againstallodds 22 분 전
Why no mining at Mt Vernon???

Closer to the mill than Fran
NBRI
gitreal gitreal 22 분 전
You're so clever.
AABB
georgie18 georgie18 23 분 전
Your very welcome…🥳
KULR
RobotDroid RobotDroid 23 분 전
Won't hold up next week as the lack of news from mute inept nonmanagement will continue as January falls to February.
NWBO
georgie18 georgie18 23 분 전
Nope…🥳
UMAV

최근 히스토리

Delayed Upgrade Clock